Management of Decompensated Cirrhosis

Immediate Priorities

The American Association for the Study of Liver Diseases recommends initiating insulin therapy as the only evidence-based diabetes treatment in decompensated cirrhosis, with a target fasting blood glucose ≤180 mg/dL to avoid hyperglycemic complications while minimizing hypoglycemia risk 1
The European Association for the Study of the Liver suggests that hypoglycemic symptoms can mimic hepatic encephalopathy, creating diagnostic confusion, and staff and family must be educated about overlapping symptoms 1
Occult urinary tract infection is a common precipitant of hepatic encephalopathy in cirrhotic patients and may be asymptomatic, according to the American Association for the Study of Liver Diseases 2

The American Association for the Study of Liver Diseases states that platelets of 104 and WBC of 3.2 are consistent with hypersplenism from portal hypertension 3
The European Association for the Study of the Liver recommends that patients with decompensated cirrhosis should be managed in specialized liver units when possible 3, 4

The American Association for the Study of Liver Diseases indicates that the MELD-Na score of 22 with recent hepatic encephalopathy indicates significant mortality risk, and early transplant referral is appropriate and time-sensitive 3, 4
The United Network for Organ Sharing recommends that patients with decompensated cirrhosis should be prioritized for liver transplantation based on their MELD-Na score 3, 4

The American Association for the Study of Liver Diseases suggests that complete blood count, comprehensive metabolic panel, and liver function tests should be monitored at least twice weekly initially, then weekly once stable 3
The European Association for the Study of the Liver recommends daily weight, vital signs, mental status assessment, and intake/output, as well as assessing for asterixis and orientation to time daily to detect early hepatic encephalopathy 2, 1

The American Association for the Study of Liver Diseases recommends identifying and treating precipitants aggressively, including infection, constipation, gastrointestinal bleeding, electrolyte abnormalities, or medications 2, 1
The European Association for the Study of the Liver suggests considering rifaximin if recurrent episodes occur despite lactulose 2

The American Association for the Study of Liver Diseases states that without liver transplantation, median survival with decompensated cirrhosis and MELD-Na 22 is approximately 1 year, and liver transplantation offers the only definitive cure 3, 5
The American Association for the Study of Liver Diseases recommends discussing prognosis and treatment goals with patient and family, ensuring advance directives are in place, and considering palliative care consultation if transplant is not feasible 3, 5

A patient with decompensated cirrhosis presents with progressive abdominal distension, lower extremity edema, and confusion episodes, which are consistent with ascites, hepatic encephalopathy, and potentially hepatorenal syndrome 6.
The patient's symptoms, including decreased urine output, early satiety, and dyspnea when lying flat, suggest a high risk of complications such as spontaneous bacterial peritonitis and hepatorenal syndrome 6.
Family members note periods of disorientation to time and personality changes, indicating Grade I-II hepatic encephalopathy 7.

The patient has hyponatremia (sodium 128 mmol/L), which is common in decompensated cirrhosis 6.
The patient's creatinine level is 1.8 mg/dL, representing Stage 2 acute kidney injury (AKI) with a >2-fold increase from baseline, indicating a need for immediate management to prevent further deterioration 8.
The patient has an INR of 1.8, indicating coagulopathy, which should not be used to gauge bleeding risk 9.
Abdominal ultrasound shows a nodular liver contour with coarse echotexture, consistent with cirrhosis, and large volume ascites 6.
Chest X-ray reveals a right-sided pleural effusion, suggesting hepatic hydrothorax 10.

Discontinue all diuretics, nephrotoxic drugs, NSAIDs, ACE inhibitors, and beta-blockers immediately to manage acute kidney injury 8, 11.
Expand plasma volume with albumin 1 g/kg (up to 100g) over 2-4 hours if hypovolemia is suspected 8.
Perform diagnostic paracentesis immediately to rule out spontaneous bacterial peritonitis, and send ascitic fluid for cell count with differential, albumin, culture, total protein, and Gram stain 6, 11.
Start lactulose 15-30 mL orally 2-3 times daily, titrate to 2-3 soft bowel movements per day, to manage hepatic encephalopathy 7.
Target mean arterial pressure of 65 mmHg with ongoing assessment of end-organ perfusion, and start norepinephrine as first-line vasopressor if hypotension persists despite volume resuscitation 10, 11.

Consult nutrition for assessment using NUTRIC score and implement early nutritional support, targeting 35 kcal/kg/day for non-obese patients and 25-35 kcal/kg/day for obese patients 9.
Protein goal: 1.2-1.5 g/kg/day using dry or ideal body weight; do not restrict protein 9.
Consider branched-chain amino acid supplementation and enteral nutrition preferred over parenteral 9.

Daily monitoring of weight, vital signs, mental status, intake/output, and clinical volume assessment is crucial 6.
The patient's prognosis is poor, with a median survival of approximately 1 year without transplantation, and liver transplantation offers the only definitive cure 6.